Publications
5891 Results
- Journal / Conference
- Urology 71(5):967-970
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID18267333
- PMC
- PMC2387066
- Study Number(s)
- SWOG-9217
Extraction of DNA from serum for high-throughput genotyping: findings from pilot studies within the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Clinical Oncology 26(20)3351-3357
- Year
- 2008
- Research Committee(s)
- Lung
- Study Number(s)
- S0342
Increased EGFR gene copy number detected by FISH predicts outcome in non-small cell lung cancer patients treated with cetuximab and chemotherapy [PMID18612151;PMC3368372]
- Journal / Conference
- Journal of Urology 180(2):544-547
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID18550097
- PMC
- https://www.ncbi.nlm.nih.gov/pubmed/18550097
- Study Number(s)
- SWOG-9217
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy
- Journal / Conference
- Journal of Clinical Oncology 26(4):626-632
- Year
- 2008
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [PMID18235122]
- Journal / Conference
- American Journal of Epidemiology 168(12):1416-1424
- Year
- 2008
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Serum steroid and sex hormone binding globulin concentrations and the risk of incident benign prostatic hyperplasia (BPH): Results from the Prostate Cancer Prevention Trial. PMC2387066; PMID: 18267333.
- Journal / Conference
- Prostate 68(13):1477-1486
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID18618736
- PMC
- PMC2564287
- Study Number(s)
- SWOG-9217
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the Prostate Cancer Prevention Trial
- Journal / Conference
- American Journal of Epidemiology 167(3):362-368
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID179821157
- PMC
- PMC2939738
- Study Number(s)
- SWOG-9217
Integrating the predictiveness of a marker with its performance as a classifier
- Journal / Conference
- Transplantation 86(2):215-222
- Year
- 2008
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-9239
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for post-transplantation lymphoproliferative disorder (PTLD) [PMID: 18645482]
- Journal / Conference
- Annals of Hematology 87(Suppl.1):S57-S59
- Year
- 2008
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0432
Phase II studies of different schedules and doses of the farnesyltransferase inhibitor tipifarnib (R11577, zarnestra) for patients age 70 or older with previously untreated acute myeloid leukemia (AML): North American Intergroup Study S0432.
- Journal / Conference
- Journal of Neurooncology 86:353-358
- Year
- 2008
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9149